1. Efficacy and safety of abemaciclib, an inhibitor of CDK4 and CDK6, for patients with breast cancer, non-small cell lung cancer, and other solid tumors;Patnaik;Cancer Discov,2016
2. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle;Goodrich;Cell,1991
3. Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes;Hino;Cancer Sci,2020
4. A population pharmacokinetic and pharmacodynamic analysis of abemaciclib in a phase I clinical trial in cancer patients;Tate;Clin Pharmacokinet,2017
5. Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer;Burstein;N Engl J Med,2020